Both in Surgical Instruments
iRadimed vs SpyGlass Pharma
Over the past year IRMD returned −20.1% and SGP returned +22.1%; their daily moves had a correlation of 0.10.
IRMD −20.1% SGP +22.1%Growth of $1, one year, split-adjusted
| Metric | IRMD | SGP |
|---|---|---|
| Price | $76.68 | $32.24 |
| Market cap | $980.5M | $1.08B |
| Today | −10.57% | −0.83% |
| 1 month | −10.1% | +21.7% |
| 6 months | −12.0% | +34.4% |
| Year to date | −21.2% | — |
| 1 year | −2.1% | — |
| Revenue growth (YoY) | +14.2% | — |
| Gross margin | 76.3% | — |
| Net margin | 26.9% | — |
| P/E (TTM) | 40.9× | — |
| Price / sales | 11.0× | — |
| Net cash | $63.3M | $234.2M |
| Dividend yield | 1.04% | — |
| Volatility (60d) | 30.3% | 45.9% |
| Short % of float | 8.1% | 20.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).